Literature DB >> 11958871

Differential regulation of pituitary adenylate cyclase-activating peptide receptor variants in the rat suprachiasmatic nucleus.

K Shinohara1, T Funabashi, T J Nakamura, D Mitsushima, F Kimura.   

Abstract

Pituitary adenylate cyclase-activating peptide is densely distributed in the suprachiasmatic nucleus, which functions as the circadian pacemaker. A receptor for pituitary adenylate cyclase-activating peptide, denoted as PAC(1), exists in six variant forms. We used reverse transcriptase-polymerase chain reaction to identify the PAC(1) variants that are expressed in the suprachiasmatic nucleus. Dominant variant forms of PAC(1) in the suprachiasmatic nucleus were PAC(1)short, PAC(1)hip, and PAC(1)hop1. By in situ hybridization, we examined 24-h profiles of mRNAs for the identified receptor variants in the suprachiasmatic nucleus in constant darkness and during the light-dark cycle. In constant darkness there were clear circadian rhythms in PAC(1)short mRNA with a peak at circadian time 4 but no rhythmicity was observed in PAC(1)hip mRNA or PAC(1)hop1 mRNA. In light-dark cycles, on the other hand, PAC(1)hip mRNA displayed a bimodal rhythm with troughs at zeitgeber time 4 and 16 but PAC(1)hop1 mRNA stayed constant during the day. These results suggest that PAC(1) splice variants are differentially regulated in the rat suprachiasmatic nucleus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958871     DOI: 10.1016/s0306-4522(01)00479-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

Review 1.  Pleiotropic pituitary adenylate cyclase-activating polypeptide (PACAP): Novel insights into the role of PACAP in eating and drug intake.

Authors:  Andrew T Gargiulo; Genevieve R Curtis; Jessica R Barson
Journal:  Brain Res       Date:  2019-12-26       Impact factor: 3.252

2.  A role for alternative splicing in circadian control of exocytosis and glucose homeostasis.

Authors:  Biliana Marcheva; Mark Perelis; Benjamin J Weidemann; Akihiko Taguchi; Haopeng Lin; Chiaki Omura; Yumiko Kobayashi; Marsha V Newman; Eugene J Wyatt; Elizabeth M McNally; Jocelyn E Manning Fox; Heekyung Hong; Archana Shankar; Emily C Wheeler; Kathryn Moynihan Ramsey; Patrick E MacDonald; Gene W Yeo; Joseph Bass
Journal:  Genes Dev       Date:  2020-07-02       Impact factor: 11.361

3.  Novel Rbfox2 isoforms associated with alternative exon usage in rat cortex and suprachiasmatic nucleus.

Authors:  L M M Partridge; D A Carter
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

Review 4.  PACAP38 and PAC1 receptor blockade: a new target for headache?

Authors:  Eloisa Rubio-Beltrán; Edvige Correnti; Marie Deen; Katharina Kamm; Tim Kelderman; Laura Papetti; Simone Vigneri; Antoinette MaassenVanDenBrink; Lars Edvinsson
Journal:  J Headache Pain       Date:  2018-08-07       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.